The federal contract IDV is a Federal Supply Schedule (FSS) contract (36F79723D006E) awarded by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 12 to Fennec Pharmaceuticals, Inc. The contract is an interim agreement under FSS Schedule 65 IB, which covers drugs, pharmaceuticals, and hematology-related products, with a ceiling value of $25,000 and a period of performance through May 30, 2023. This IDV supports the VA's objective of providing veterans with timely...
The provided information details a Federal Supply Schedule (FSS) contract award to Aveo Pharmaceuticals, Inc. by the U.S. Department of Veterans Affairs (VA) under the Pharmaceuticals and Drugs (FSS-61-IB) master schedule. The $45,580,967.00 ceiling value contract has an ultimate completion date of October 14, 2026. The contract aims to procure pharmaceutical and hematology-related products to support the VA's healthcare operations. As an FSS contract, it allows for the placement of task...
The Department of Veterans Affairs (VA) has awarded Ferring Pharmaceuticals Inc., a for-profit pharmaceutical manufacturer, a multiple-award indefinite-delivery vehicle (IDV) contract against the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB), valued at $98.2 million over five years. This contract enables Ferring to supply the oncology medication Adstiladrin (nadofaragene firadenovec) to various Veterans Integrated Service Networks (VISNs) across the United States to support the...
The U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) has awarded Scpharmaceuticals Inc., a for-profit pharmaceutical company based in Lexington, MA, a Federal Supply Schedule (FSS) contract valued at $600,875.40. This multiple-award, indefinite-delivery, indefinite-quantity (IDIQ) contract, designated as FSS 65 IB, covers the provision of drugs, pharmaceuticals, and hematology-related products to VA facilities over a five-year period ending in November 2028. In...
The contract is a Federal Supply Schedule (FSS) awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Eyevance Pharmaceuticals LLC, a foreign-owned for-profit manufacturer. The FSS contract is under Schedule 65 IB for Drugs, Pharmaceuticals, & Hematology Related Products, with a potential value of $450,000 and a period of performance through December 14, 2024. The contract aims to procure a range of pharmaceutical and drug products from the vendor. As an FSS...
This Federal Supply Schedule (FSS) contract was awarded by the Department of Veterans Affairs (VA) to NS Pharma, Inc., a foreign-owned for-profit manufacturer of pharmaceutical and hematology-related products. The contract, with a ceiling value of $225,000, has an ultimate completion date of March 14, 2026 and was originally awarded on March 15, 2021. The scope of the contract includes the provision of "Drugs, Pharmaceuticals, & Hematology Related Products" under the GSA Schedule...
The Federal Supply Schedule (FSS) contract awarded to Fera Pharmaceuticals, LLC is for the procurement of pharmaceutical drugs, pharmaceuticals, and hematology-related products. The prime contractor, Fera Pharmaceuticals, is a woman-owned small business that supplies the Department of Veterans Affairs (VA) and other government agencies with these products. The FSS contract, valued at up to $450,000.00, was awarded by the VA's Veterans Health Administration Veterans Integrated Service Network...
This Federal Supply Schedule (FSS) contract, awarded by the U.S. Department of Veterans Affairs (VA) to Nobelpharma America, LLC, a foreign-owned, self-certified small disadvantaged business, is for the delivery of pharmaceutical and hematology-related products under Federal Supply Class 65 I B. The contract has a ceiling value of $225,000 and a period of performance through May 2028. In addition to the FSS contract, Nobelpharma America, LLC holds a single-award Blanket Purchase Agreement...
This Federal Supply Schedule (FSS) contract was awarded by the Veterans Integrated Service Network 12 (VISN 12) of the Department of Veterans Affairs (VA) to Veloxis Pharmaceuticals, Inc. The contract has a ceiling value of $64,557,260.00 and a period of performance from July 1, 2022 to June 30, 2027. The contract is for the procurement of drugs, pharmaceuticals, and hematology-related products under the Pharmaceuticals and Drugs (FSS-61-IB) Federal Supply Schedule. As a multiple award contract,...
The Department of Veterans Affairs (VA) awarded a Federal Supply Schedule (FSS) contract, valued at up to $3.5 million, to Calliditas Therapeutics US Inc., a foreign-owned, for-profit pharmaceutical company. The contract, under the Pharmaceuticals and Drugs (FSS-61-IB) schedule, facilitates the procurement of TARPEYO, an innovative treatment for uncontrolled protein in urine due to primary immunoglobulin A nephropathy, a serious renal condition impacting some veterans. In addition to the FSS...